About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Gait Analysis in Multiple Sclerosis Patients

Gait Analysis in Multiple Sclerosis Patients

NCT05299151·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Istanbul Kültür University

With

Istanbul University - Cerrahpasa

Age

25–60

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Between aged 25-60 years
Diagnosed with MS for at least 5 years
Relapsing and progressive MS according to Mc Donald criteria
EDSS score of ≤ 3.5 ≤ 6
Modified Ashworth Scale \< 3
Being eligible to work by a neurologist

You may not be if

Having had an MS-related attack in the 3 months before the study
Changes in medications within 6 months prior to the study
To have participated in the rehabilitation program within 1 month before the study
Serious neurological, cardiac, pulmonary, rheumatological, audiovisual, or orthopedic disorders that limit assessments and/or intervention programs

The record

StatusCompleted

PhaseNo phase

Taking part22

StartedJun 2022

UpdatedJul 9, 2024

Conditions

Multiple Sclerosis 3D Gait Analysis Vestibular Rehabilitation

Where1

Istanbul University - Cerrahpaşa, Vocational School of Health Services
Istanbul, Turkey (Türkiye)